Biora Therapeutics, Inc (BIORQ) Key Ratios
$0.22
As on 04-Sep-2026 16:00EDT
Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -89.94 | -- | -98.69 | -96.22 | -87.44 |
| EBIT | -384.79 | 71.43 | -199.55 | -2.21 | 0.03 |
| Net Profit | -384.64 | 74.95 | -225.27 | 10.67 | 0.76 |
| EPS | -384.64 | 89.70 | -80.77 | 24.19 | 14.73 |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-23 | Dec-22 | Dec-21 |
| EBIT-Margin
| -963,693.84 | -578,264.72 | -2,865,225.00 | -12,544.26 | -13,312.27 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| 116.20 | 159.07 | 121.86 | 40.75 | 185.99 |
| Return on Capital
| 144.24 | -326.71 | 920.15 | -111.50 | -375.93 |
| Return on Assets
| -158.52 | -152.32 | -292.93 | -47.00 | -135.61 |
| Debt to Equity (x)
| -- | -- | -0.47 | -1.26 | -1.49 |
The underlying data is unavailable.